Ads
related to: generic zytiga- Common Side Effects
Learn About Possible Side Effects
When Taking NUBEQA®.
- Treats 2 Indications
Learn More About NUBEQA®
Indications On The Patient Site.
- What Is NUBEQA®?
When It's Time To Take Action,
There's NUBEQA®. Learn More Here.
- Questions To Ask Your Doc
How To Talk To Your Doctor About
NUBEQA®. Download The Questions.
- 1-Month Free Trial
Get 1 Month Of Free Medication For
New NUBEQA® Patients. Call Bayer.
- Downloadable Resources
Download The Patient Brochure For
More NUBEQA® Information.
- Common Side Effects
Search results
Johnson & Johnson (JNJ) Up 5.3% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Johnson & Johnson (JNJ). Shares have added...
J&J (JNJ) Q1 Earnings & Sales Top, 2023 View Up, Stock Rises
Zacks via Yahoo Finance· 1 year agoJohnson & Johnson’s JNJ first-quarter 2023 earnings came in at $2.68 per share, which beat the Zacks...
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
Healthcare Dive via Yahoo Finance· 6 months agoBig questions hang over the California health insurer's bold experiment — having five vendors carry...
J&J (JNJ) Beats on Q2 Earnings & Sales, Lowers 2022 Guidance
Zacks via Yahoo Finance· 2 years agoJohnson & Johnson’s JNJ second-quarter 2022 earnings came in at $2.59 per share, which beat the...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 2 weeks agoJohnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...
J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off
Zacks via Yahoo Finance· 6 months agoJohnson & Johnson’s JNJ third-quarter 2023 earnings came in at $2.66 per share, which beat the Zacks...
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 months agoIt has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...
J&J (JNJ) to Begin Q4 Earnings Season for Pharma Sector
Zacks via Yahoo Finance· 1 year agoGrowth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 1 week agoThis week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed...
Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?
Zacks via Yahoo Finance· 1 year agoIn J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara...
Ads
related to: generic zytiga
